The Institute for Patient Access (IFPA) review of Medicare data for patients with rheumatoid arthritis (RA), Crohn’s disease or immunodeficiency found that concerns about the negative consequences of non-medical switching are warranted. Specifically, they concluded that non-medical switching can negatively impact patient care and increase healthcare expenses, particularly for RA patients.